Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > LPA

LPA

Brief Information

Name:Apolipoprotein(a)
Target Synonym:LPA,Apo(a)
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
LPA-H52H3 Human Human LPA Protein, His Tag
LPA-H52H3-structure
LPA-H52H3-sds
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Pelacarsen IONIS-681257; ISIS-681257; TQJ-230 Phase 3 Clinical Ionis Pharmaceuticals Inc Atherosclerosis; Renal Insufficiency; Hyperlipoproteinemias; Cardiovascular Diseases; Hepatic Insufficiency; Aortic Valve Stenosis Details
Olpasiran ARO-LPA; AMG-890; ARC-LPA; RNAi ARC-LPA Phase 3 Clinical Arrowhead Pharmaceuticals Inc, Amgen Inc Plaque, Atherosclerotic; Atherosclerosis; Cardiovascular Diseases; Hepatic Insufficiency Details
Muvalaplin LY-3473329 Phase 2 Clinical Eli Lilly And Company Renal Insufficiency; Lipid Metabolism Disorders Details
[14C]-LY3473329 [14C]-LY3473329 Phase 1 Clinical Eli Lilly And Company Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message